CryoPort (CYRX) Competitors $8.20 -0.55 (-6.29%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$8.28 +0.08 (+0.91%) As of 08/7/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. MENS, SDGR, DYN, EVO, JANX, TVTX, ANIP, AUPH, WVE, and ETNBShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Jyong Biotech (MENS), Schrodinger (SDGR), Dyne Therapeutics (DYN), Evotec (EVO), Janux Therapeutics (JANX), Travere Therapeutics (TVTX), ANI Pharmaceuticals (ANIP), Aurinia Pharmaceuticals (AUPH), WAVE Life Sciences (WVE), and 89BIO (ETNB). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Jyong Biotech Schrodinger Dyne Therapeutics Evotec Janux Therapeutics Travere Therapeutics ANI Pharmaceuticals Aurinia Pharmaceuticals WAVE Life Sciences 89BIO Jyong Biotech (NASDAQ:MENS) and CryoPort (NASDAQ:CYRX) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Do institutionals & insiders have more ownership in MENS or CYRX? 92.9% of CryoPort shares are held by institutional investors. 10.0% of CryoPort shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is MENS or CYRX more profitable? CryoPort has a net margin of 37.21% compared to Jyong Biotech's net margin of 0.00%. Jyong Biotech's return on equity of 0.00% beat CryoPort's return on equity.Company Net Margins Return on Equity Return on Assets Jyong BiotechN/A N/A N/A CryoPort 37.21%-10.48%-5.56% Do analysts rate MENS or CYRX? CryoPort has a consensus target price of $12.00, indicating a potential upside of 46.34%. Given CryoPort's stronger consensus rating and higher probable upside, analysts clearly believe CryoPort is more favorable than Jyong Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jyong Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00CryoPort 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media favor MENS or CYRX? In the previous week, CryoPort had 17 more articles in the media than Jyong Biotech. MarketBeat recorded 17 mentions for CryoPort and 0 mentions for Jyong Biotech. CryoPort's average media sentiment score of 0.26 beat Jyong Biotech's score of 0.00 indicating that CryoPort is being referred to more favorably in the news media. Company Overall Sentiment Jyong Biotech Neutral CryoPort Neutral Which has preferable valuation and earnings, MENS or CYRX? Jyong Biotech has higher earnings, but lower revenue than CryoPort. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJyong BiotechN/AN/AN/AN/AN/ACryoPort$228.38M1.80-$114.76M$1.336.17 SummaryCryoPort beats Jyong Biotech on 10 of the 12 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$438.70M$5.63B$7.23B$9.57BDividend YieldN/A2.29%706.08%4.18%P/E Ratio6.1710.2713.4225.14Price / Sales1.801.19532.48102.95Price / CashN/A10.587.7958.58Price / Book1.103.012.125.59Net Income-$114.76M$184.70M$571.16M$265.48M7 Day Performance12.79%1.52%2.73%1.22%1 Month Performance7.89%-4.38%0.24%0.39%1 Year Performance0.49%-6.43%3.84%23.47% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort3.6576 of 5 stars$8.20-6.3%$12.00+46.3%+5.5%$438.70M$228.38M6.171,186Trending NewsEarnings ReportAnalyst UpgradeAnalyst RevisionMENSJyong BiotechN/A$23.46+22.7%N/AN/A$1.45BN/A0.0031Gap DownSDGRSchrodinger2.2847 of 5 stars$19.99+2.4%$32.75+63.8%+7.3%$1.43B$207.54M0.00790Earnings ReportGap UpDYNDyne Therapeutics3.4901 of 5 stars$10.25+2.0%$36.25+253.7%-73.5%$1.43BN/A0.00100Upcoming EarningsAnalyst ForecastEVOEvotec2.1211 of 5 stars$3.88-3.5%$5.90+52.1%+26.1%$1.43B$862.40M0.004,827Upcoming EarningsGap UpJANXJanux Therapeutics2.2713 of 5 stars$23.91+1.5%$91.89+284.3%-36.0%$1.39B$10.59M0.0030Earnings ReportTVTXTravere Therapeutics2.1748 of 5 stars$15.96+2.1%$32.14+101.4%+100.8%$1.39B$233.18M0.00460News CoverageAnalyst ForecastANIPANI Pharmaceuticals3.6709 of 5 stars$65.43+2.3%$78.88+20.5%+21.0%$1.38B$614.38M-51.52600AUPHAurinia Pharmaceuticals2.1371 of 5 stars$11.45+9.2%$12.00+4.8%+114.8%$1.38B$235.13M20.57300Insider TradeHigh Trading VolumeWVEWAVE Life Sciences4.691 of 5 stars$8.75+1.4%$20.27+131.6%+36.0%$1.37B$108.30M0.00240ETNB89BIO1.5573 of 5 stars$9.34+2.0%$26.43+183.0%+17.0%$1.34BN/A0.0040Earnings Report Related Companies and Tools Related Companies Jyong Biotech Competitors Schrodinger Competitors Dyne Therapeutics Competitors Evotec Competitors Janux Therapeutics Competitors Travere Therapeutics Competitors ANI Pharmaceuticals Competitors Aurinia Pharmaceuticals Competitors WAVE Life Sciences Competitors 89BIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredFuturist Eric Fry says it will be a “Summer of Surge” for these three stocksWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts